The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Multiple Sclerosis Ireland .

Filed returns
184
match these filters
Matching filed returns per period 0 5 10 15 20 Sep–Dec 2015: 2 filed returns Jan–Apr 2016: 5 filed returns May–Aug 2016: 4 filed returns Sep–Dec 2016: 6 filed returns Jan–Apr 2017: 3 filed returns May–Aug 2017: 5 filed returns Sep–Dec 2017: 5 filed returns Jan–Apr 2018: 6 filed returns May–Aug 2018: 4 filed returns Sep–Dec 2018: 9 filed returns Jan–Apr 2019: 5 filed returns May–Aug 2019: 4 filed returns Sep–Dec 2019: 3 filed returns Jan–Apr 2020: 3 filed returns May–Aug 2020: 9 filed returns Sep–Dec 2020: 2 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 2 filed returns Sep–Dec 2021: 2 filed returns Jan–Apr 2022: 3 filed returns May–Aug 2022: 10 filed returns Sep–Dec 2022: 5 filed returns Jan–Apr 2023: 3 filed returns May–Aug 2023: 18 filed returns Sep–Dec 2023: 14 filed returns Jan–Apr 2024: 7 filed returns May–Aug 2024: 8 filed returns Sep–Dec 2024: 10 filed returns Jan–Apr 2025: 5 filed returns May–Aug 2025: 5 filed returns Sep–Dec 2025: 2 filed returns Jan–Apr 2026: 4 filed returns May–Aug 2026: 10 filed returns 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2018 Multiple Sclerosis Ireland Health Investment in neurology services (Matters involving public funds) 20 On lobbying.ie
Jan–Apr 2018 Multiple Sclerosis Ireland Health Neurorehabilitation (Public policy or programme) 9 On lobbying.ie
Jan–Apr 2018 Multiple Sclerosis Ireland Health Access to new MS medications (Matters involving public funds) 6 On lobbying.ie
Jan–Apr 2018 Multiple Sclerosis Ireland Health New MS medication ocrelizumab (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2017 Multiple Sclerosis Ireland Health Meeting with Minister Jim Daly with other organisations involved in the Invest in Home Care campaign, to ask questions in relation to the next steps in the process of the recent consultation on home care. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2017 Multiple Sclerosis Ireland Health Submissions made to the Department of Health consultations on establishing a statutory home care scheme, Personalised Budgets and draft Health Information Policy Framework (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2017 Multiple Sclerosis Ireland Health Funding for MS Care Centre, 65 Bushy Park Road, Rathgar, Dublin 6 (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2017 Multiple Sclerosis Ireland Health Letter to Minister Simon Harris regarding potential new pilot programme for reimbursement of new treatment for primary progressive MS, ocrelizumab. (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2017 Multiple Sclerosis Ireland Health Implementation of the National Neurorehabilitation Strategy (Public policy or programme) 67 On lobbying.ie
May–Aug 2017 Multiple Sclerosis Ireland Health Raised issue of inappropriate placement in nursing homes of people with MS (Public policy or programme) 1 On lobbying.ie
May–Aug 2017 Multiple Sclerosis Ireland Health Letter to Minister Simon Harris regarding the need to protect the titles of Physiotherapist and Physical Therapist and expressing concern about the upcoming Health and Social Care Professionals Amendment Bill (Public policy or programme) 1 On lobbying.ie
May–Aug 2017 Multiple Sclerosis Ireland Health Meeting regarding need to invest in home care services (Public policy or programme) 1 On lobbying.ie
May–Aug 2017 Multiple Sclerosis Ireland Health Meeting regarding availability of cannabis-based MS medication Sativex (Matters involving public funds) 1 On lobbying.ie
May–Aug 2017 Multiple Sclerosis Ireland Health Need for investment in neurology services and development of implementation plan for National Clinical Programme for Neurology Model of Care (Matters involving public funds) 30 On lobbying.ie
Jan–Apr 2017 Multiple Sclerosis Ireland Health Requesting publication of implementation plan for the National Clinical Programme for Neurology Model of Care, with budgets and timescales (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2017 Multiple Sclerosis Ireland Health Requesting additional funding for the Multiple Sclerosis Care Centre - 12 bed respite care facility in Rathgar, Dublin (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2017 Multiple Sclerosis Ireland Health Reimbursement of cannabis-based MS medication Sativex (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2016 Multiple Sclerosis Ireland Health Protection of job titles of Physiotherapist and Physical Therapist (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2016 Multiple Sclerosis Ireland Health Funding for neurology services (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2016 Multiple Sclerosis Ireland Health Funding arrangements for MS medications Tysabri and Lemtrada (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2016 Multiple Sclerosis Ireland Health Sativex - availability of licensed MS medication (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2016 Multiple Sclerosis Ireland Health Neurorehabilitation - need to invest in and develop neurorehabilitation services (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2016 Multiple Sclerosis Ireland Health Medical Cards (Public policy or programme) 1 On lobbying.ie
May–Aug 2016 Multiple Sclerosis Ireland Health Meetings regarding MS Ireland's general advocacy agenda. (Public policy or programme) 2 On lobbying.ie
May–Aug 2016 Multiple Sclerosis Ireland Health Advocacy work regarding the MS medication Fampyra (Matters involving public funds) 1 On lobbying.ie
May–Aug 2016 Multiple Sclerosis Ireland Health Advocacy work relating to the cannabis-based MS medication Sativex (Matters involving public funds) 2 On lobbying.ie
May–Aug 2016 Multiple Sclerosis Ireland Health Neurorehabilitation (Public policy or programme) 10 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Requesting meeting to discuss issues in the MS Ireland 2016 Advocacy Statement: http://www.ms-society.ie/uploads/File/Community/MS%20Ireland%20Advocacy%20Statement%2021012016.pdf (Matters involving public funds) 2 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Letter to Tony O'Brien regarding availability of MS medications that are currently only available via individual hospital budgets (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Question raised to the Director General of the HSE on the issue of underfunding for neurology services, via the National Patients' Forum (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Communication with the HSE regarding the systems for the reimbursement of the MS medication Fampyra. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Reimbursement of MS medication Sativex (Matters involving public funds) 2 On lobbying.ie
Sep–Dec 2015 Multiple Sclerosis Ireland Health Implementation of the National Policy and Strategy for the Provision of Neuro-Rehabilitation Services 2011-2015 (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2015 Multiple Sclerosis Ireland Health Implementation of the National Policy and Strategy for the Provision of Neuro-Rehabilitation Services 2011-2015 (Matters involving public funds) 2 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 184 100.0%